ABS — Arctic Bioscience AS Balance Sheet
0.000.00%
- NOK89.49m
- NOK149.68m
- NOK40.10m
Annual balance sheet for Arctic Bioscience AS, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | NAS | NAS | NAS | NAS | NAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 227 | 144 | 79.6 | 3.28 | 1.29 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11 | 18.7 | 20.8 | 25.6 | 18.4 |
| Total Inventory | |||||
| Total Current Assets | 267 | 198 | 133 | 57.9 | 49.3 |
| Net Property, Plant And Equipment | 16 | 22.3 | 26.4 | 24.5 | 22.8 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 341 | 328 | 300 | 280 | 285 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.9 | 40.4 | 39.6 | 67.5 | 83 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 20.9 | 40.4 | 41.7 | 69 | 111 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Total Equity | 321 | 287 | 259 | 211 | 173 |
| Total Liabilities & Shareholders' Equity | 341 | 328 | 300 | 280 | 285 |
| Total Common Shares Outstanding |